Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France.

Ningbo Aocheng Biotechnology Co., Ltd., established on 2009-02-16, Business scope includes general items:Biochemical product technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Class I Medical Device Leasing;software development;Artificial intelligence application software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Medical Research and Experimental Development;Conference and Exhibition Services;Technology Import and Export;Import and export;market survey(Does not include foreign investigations);Bidding agency service;marketing planning;Mechanical Parts,Parts sales;Instrument sales;Machinery sales;electronics sales;Experimental analysis instrument sales;software sales;Office Supplies Sales;Glassware Sales;Sales of plastic products;Sales of technical glass products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;Production of Class III Medical Devices;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Sichuan Jinyu Medical Laboratory Co., Ltd., established on 2010-03-03, Business scope includes licensed projects:medical service;Inspection and testing service;Class III medical device business;road freight transport(Does not contain dangerous goods);Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of Class II Medical Devices;Class II Medical Device Leasing;Sales of Class I Medical Devices;Class I Medical Device Leasing;Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Development of Human Gene Diagnosis and Therapy Technology;Domestic Freight Forwarding;total mass4.5Road freight transport of ordinary freight vehicles of 1 ton or less(Except network freight and dangerous goods);General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Labor service(Does not include labor dispatch);software development;Information Technology Consulting Services;Information system integration service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

"Shanghai Chemtron Biotech Co., Ltd. is a global rapid diagnostic test manufacturer.Founded in 2001,Shanghai Chemtron Biotech Co. has been committed to manufacturing in vitro diagnostic test kits sold around the world.Chemtron has established business relationships with over 60 countries through Chemtron's test kits under the Chemtrue brand as well as OEM packing. Chemtron's manufacturing site is located in Shanghai, China and houses 130,000 square feet of state-of-the-art medical diagnostic test manufacturing space.Chemtron's US office is located in San Diego,California. Chemtron currently has ISO 13485:2012 certification.The majority of products are CE approved with some products being registered with FDA.Chemtron continues to improve its quality system in order to bring reliable and consistent products to their customers. With over 15 years of successful commercial manufacturing experience,Chemtron's dedicated team of scientists,engineers and technicians offer substantial labor anf overhead cost efficiencies."

Tosoh Corp. engages in the manufacture and sale of basic chemicals, petrochemicals, fine chemicals, and specialty products. It operates through the following segments: Petrochemicals, Chlor-alkali, Specialty, Engineering, and Others. The Petrochemical segment offers olefins and polymers. The Chlor-alkali segment provides caustic soda, vinyl chloride monomer, polyvinyl chloride, high-performance polyurethane, organic chemicals, urethane raw materials, and cement. The Specialty segment handles inorganic or organic fine product, measurement and diagnostic products, electronic materials that include quartz glass and sputtering target. The Engineering segment deals with water treatment equipment and construction. The Others segment manages transportation and warehousing, inspection and analysis, and information processing businesses. The company was founded on February 11, 1935 and is headquartered in Tokyo, Japan.

Shenzhen Jinzhun Biomedical Engineering Co., Ltd., established on 2014-03-07, Business scope includes general business items:equipment,medical equipment,diagnostic instrument,Diagnostic reagents,software,Consumables,Research and development of biological products;Chemical Products(Free of Hazardous Chemicals)promotion of;Import and export of goods and technology;Invest in business(Specific projects will be reported separately);Domestic Trade.,The licensing program is:equipment,medical equipment,diagnostic instrument,Diagnostic reagents,software,Consumables,Production and sales of biological products.

Part of Becton, Dickinson & Co., Becton, Dickinson & Co. Ltd. is an Irish company located in Dublin. The firm manufactures and supplies medical devices.

Getein Biotech, Inc. engages in the business of medical health industry chain. It focuses on the development, production, sales and service of in vitro diagnostic products. Its products include diagnostic reagent; diagnostic analyzer; calibrator; quality control such as cardiac markers, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus; and raw material such as antigen, monoclonal antibody, polyclonal antibody, antiserum, and microsphere. The company was founded by En Ben Su on March 8, 2002 and is headquartered in Nanjing, China.

Shamu (Shanghai) Biotechnology Co., Ltd., established on 2016-11-29, The scope of business includes engaging in biotechnology,Technology development in the field of medical technology,technical consulting,Technical Services,Business Management Consulting,Nutrition and Health Consulting Services,Special packaging equipment,laboratory equipment,Clean equipment,Optical Instruments,beauty equipment,Ι class medical device,Daily necessities,Sports Equipment,Fitness Equipment,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),plastic products,Electrical Equipment,Wujinjiaodian,Instrument sales. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Suzhou Hongxun Biotechnology Co., Ltd., established on 2013-08-07, Business scope includes research and development of biotechnology and bioinformatics reagents and products,Engage in the import and export of the above commodities and technologies,Sell ​​products developed by the company and provide technology transfer,Technical Support,After-sales service and other related services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Manufactures and sells pharmaceutical products

Shenzhen Boshi Diagnostic Technology Co., Ltd., established on 2012-11-23, Business scope includes general business items:none,The licensing program is:Research and development of in vitro diagnostic instruments and reagents and related technical services.Manufacture and sales of medical devices(Class I medical device,Class II medical device,Class II in vitro diagnostic reagents,Class III medical devices,Class III in vitro diagnostic reagents),medical instruments(New Diagnostic Reagents)development,Production;electronic product,Communication Products,Information system,computer software,Veterinary equipment(Contains veterinary medical devices),household appliance,Research and development of disinfection products,Production,wholesale,retail,import and export,After-sales service and related supporting business;Engaged in technical development of medical devices,technical consulting,technology transfer,Technical Services,Technology import and export business(Does not involve special management measures for foreign investment access);engaged in industrial design,Computer software design, development and consulting(No restricted items);electronic product,Communication Products,Testing of Medical Devices,consultation service.(Involves supporting license management,Commodities managed by special regulations shall be handled in accordance with relevant state regulations).

Hangzhou Prome Biotechnology Co., Ltd., established on 2019-03-01, Business scope includes technology development,technical consulting:Biotechnology,medical technology,Drug intermediate.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Tiger Kexin Biotechnology Co., Ltd., established on 2004-08-06, Business scope includes technology development,Technical Services,technical consulting(Except intermediary);Sales of Class I medical devices,Class II medical device;Import and export(Excluding state trade management goods);Production of Class I medical devices;Sales of Class III Medical Devices;Production of the second class,Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production of the second class,Class III medical devices,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.).

IBIDEN Co., Ltd. engages in the manufacture and sale of electronics, ceramics, housing materials, and resin products. It operates through the following segments: Electronics, Ceramics, and Others. The Electronics segment covers printed wiring boards, package substrates, and pattern design for printed wiring boards. The Ceramics segment manufactures and sells environment-related ceramic products, graphite specialty products, ceramics fiber, and fine ceramic products. The Others segment processes synthetic resin, agricultural, and marine products; sells petroleum products, and provides information services. The company was founded on November 25, 1912 and is headquartered in Ogaki, Japan.

Shenzhen Daai Medical Technology Co., Ltd., established on 2012-04-06, Business scope includes general business items:IIkind6826Technical development of physical therapy and rehabilitation equipment;Medical Device Software,In vitro diagnostic reagents,Research and development of biological products;Invest in business(Specific projects will be reported separately);Domestic Trade;Import and export of goods and technology;service industry;furniture sales.(law,Administrative regulations,Except for projects that are required to be approved before registration by decision of the State Council),The licensing program is:IIkind6826Production of physical therapy and rehabilitation equipment;IIkind,IIIsales of medical devices;furniture manufacturing.